chrisvoncsefalvay/vaers-outcomes huggingface dataset:
He is cleared of Covid now but he missed his second dose 16Apr2021; A week later he ended up getting Covid; This is a spontaneous report from a Pfizer sponsored program. A contactable consumer (patient) reported a male patient of an unspecified age received first dose of bnt162b2 (BNT162B2, Solution for injection), via an unspecified route of administration on 26Mar2021 as single dose for covid-19 immunization. The patient's medical history and concomitant medications were not reported. On an unspecified date in Mar2021, the patient experienced a week later he ended up getting covid. On 16Apr2021, the patient experienced he is cleared of covid now but he missed his second dose 16Apr2021. Caller got his first dose of the vaccine last 26Mar2021. A week later he ended up getting Covid. He is cleared of Covid now but he missed his second dose schedule last 16Apr2021. He called in to know the protocol to take or if he can still get the second dose of the vaccine. The patient did not receive any treatment for the events. The clinical outcomes of the a week later he ended up getting Covid was recovered and of the he is cleared of Covid now but he missed his second dose 16Apr2021 was unknown.   No follow-up attempts are possible. Information about lot/batch number cannot be obtained.
Received Moderna vaccines on 1/4/21, 6/8/21, 1/11/22; 1st dose Lot # not documented in chart.   COVID positive on 4/23/22 by PCR. Admitted to hospital on 4/23/22 w/ hypoxia, COVID pneumonia. Underlying COPD, h/o PE, HTN.
Started having a sore throat and congestion. Took a home COVID-19 test and was positive. Went to a clinic and was prescribed PAXLOVID. Started feeling better and took another home COVID-19 test and was negative. Started feeling bad again a week later and just rested.
40 minutes after vaccination, developed hives, chest tightness, lip/cheek/tongue numbness/tingling, nausea Took Benadryl 50 mg and Pepcid 40 mg at 7:15pm. Continued with Zofran every 8 hours
Information has been received from a registered nurse referring to an unknown number of unspecified patients of unknown ages and genders. The patients' medical histories and concurrent conditions were not reported. On unknown dates in 2016 (reported as "unknown dates starting on or after 15-JAN-2016") the patients were administered with improperly stored doses of GARDISAL (dose, route, lot# and expiration date not reported). The vaccine was improperly stored at 0 degrees for 90 hours. Data logger was involved. There was no previous temperature excursion. No adverse effect was reported. This is one of several reports received from the same reporter. Additional information has been requested.
sore arm; (lump in arm) that is very red and raised; (lump in arm) that is very red; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm), VACCINATION SITE MASS ((lump in arm) that is very red and raised) and ERYTHEMA ((lump in arm) that is very red) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030A21A) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure. Concomitant products included IRON, VITAMIN D NOS, CURCUMIN (TURMERIC MERIVA), HYDROCODONE, CINNAMON [CINNAMOMUM VERUM], GABAPENTIN and ACETIC ACID (SUMMERS EVE VINEGAR - WATER) for an unknown indication.    On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Mar-2021, the patient experienced PAIN IN EXTREMITY (sore arm), VACCINATION SITE MASS ((lump in arm) that is very red and raised) and ERYTHEMA ((lump in arm) that is very red). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (sore arm), VACCINATION SITE MASS ((lump in arm) that is very red and raised) and ERYTHEMA ((lump in arm) that is very red) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication included blood pressure medicine
ACUTE PULMONARY EMBOLISM 10/21/2022  --  RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS
Patient received a dose of the 5-11 Pfizer COVID vaccine undiluted. NO ADVERSE SYMPTOMS occured day of injection. Consulted pharmacist and notified mother. Will follow up in a few days again to check in.
High fever; Feel tired; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 39 year-old female patient received bnt162b2 (BNT162B2), administered in arm right, administration date 18Nov2021 16:30 (Lot number: 30125BA) at the age of 39 years as dose 1, single for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. The following information was reported: PYREXIA (non-serious) with onset 2021, outcome "recovered" (2021), described as "High fever"; FATIGUE (non-serious) with onset 2021, outcome "recovered" (2021), described as "Feel tired". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of pyrexia. Additional information: No prior vaccination within 4 Weeks. Treatment included Tylenol and Motrin.  No follow-up attempts are possible. No further information is expected.
Acute appendicitis presented and diagnosed April 6, 2021. Treated nonsurgically due to active COVID-19 infection at time of hospitalization. Hospitalized again on April  23 to treat an abdominal abscess caused by appendiceal perforation. Appendix was later removed (May 20, 2021) following COVID-19 recovery and treatment of the abscess.
Information has been received from a nurse concerning a 20 year old female who on unspecified dates was vaccinated with the first and second dose of Gardasil (lot#unknown). On 18-JUN-2007 the patient was vaccinated with a third dose of Gardasil (lot # 658490/0802U) IM. Concomitant therapy included hormonal contraceptives (unspecified). On 18-JUN-2007, the patient fainted within minutes of being vaccinated. Medical attention was sought. The patient was taken to the ER. At the time of reporting the patient had recovered. No further information was provided. Additional information has been requested.
Patient was approx 5 wks preg. at time of vaccination. Went on for routine follow-up with her ob/gyn 11/28/09 ultrasound revealed embryo was not alive. Pt has hx of 2 prior miscarriages.
Swelling neck (injection side); Swelling on cheek (injection side); Swelling on scalp (injection side); This non-serious case was reported by a physician via sales rep and described the occurrence of cheek swelling in a child male patient who received Men B NVS (Bexsero) for prophylaxis.   The patient's past medical history included atopic dermatitis, psoriasis and highly allergic.   In MAR-2023, the patient received the 1st dose of Bexsero (unknown arm). In MAR-2023, 72 hrs after receiving Bexsero, the patient experienced cheek swelling (Verbatim: Swelling on cheek (injection side)), neck swelling (Verbatim: Swelling neck (injection side)) and scalp swelling (Verbatim: Swelling on scalp (injection side)). The outcome of the cheek swelling, neck swelling and scalp swelling were unknown.   It was unknown if the reporter considered the cheek swelling, neck swelling and scalp swelling to be related to Bexsero and Bexsero Pre-Filled Syringe Device.     It was unknown if the company considered the cheek swelling, neck swelling and scalp swelling to be related to Bexsero and Bexsero Pre-Filled Syringe Device.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK receipt date: 24-Mar-2023 The patient received first dose of Bexsero a few weeks ago from reporting. The patient experienced swelling on his cheek, neck, and scalp on the same side as the injection, only on one side received the injection.  A GSK field representative did not have a specific date for the injection, which arm the injection received in, which side the swelling was on or any further details about the patient's history.  The reporter did not know when the historical atopic dermatitis, psoriasis, and being highly allergic began so, no specific date provided.  The reporter consented to follow up.
first dose 18-24 months ago. Second not yet received.; This case was reported by a nurse via call center representative and described the occurrence of incomplete course of vaccination in a patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received 1st dose between 18 to 24 months ago).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  Additional details were provided as follows: The age at vaccination was not applicable for this report. Till the time of reporting, the patient did not receive 2nd dose of Shingrix, which led to incomplete course of vaccination. The reporter consented to follow up.
Day 1 - shakes, arm ache - could not move   Day 2 - low grade temperature - limited motion in arm (could not raise)   Day 3 - low grade temperature - still could not lift or raise arm at shoulder - Day 4 - returned movement of arm but could not lift anything heavy above shoulder.  Day 5 - full motion with some light discomfort
Chickenpox in a Vaccinated Adult; Chickenpox in a Vaccinated Adult; This literature marketed report has been received from the authors of a published literature article, titled as stated below and refers to a 37-year-old male patient.  At age 20, the patient was vaccinated with two doses of varicella virus vaccine live (oka/merck) (VARIVAX) (dose, route of administration, lot # and expiration date were not provided) for prophylaxis.  The patient presented with a pruritic rash, chills, and body aches for three days. He was afebrile and had scattered vesicles on an erythematous base, on his trunk and extremities. He reported never having chickenpox. He worked at a nursing home where a resident had recently developed shingles. Vesicular fluid polymerase chain reaction (PCR) testing was positive for varicella zoster, consistent with chickenpox. The patient developed chickenpox almost two decades after being vaccinated. The patient was treated with a 7-day course of valacyclovir and was advised to stay home from work for two weeks.  The outcome of the events was unknown. The authors considered the events to be related to varicella virus vaccine live (oka/merck) (VARIVAX).  A copy of the published article is attached as further documentation of the patient's experience.
nausea; DIARRHEA; This is a spontaneous report received from contactable reporter(s) (Other HCP and Consumer or other non HCP) for a Pfizer sponsored program.  A 29 year-old male patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 2, single and (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation; bosutinib (BOSULIF) (Batch/Lot number: unknown, Expiration Date: 31Dec2023) at 500 mg (500mg). The patient's relevant medical history and concomitant medications were not reported. The following information was reported: NAUSEA (non-serious), outcome "unknown", described as "nausea"; DIARRHOEA (non-serious), outcome "unknown", described as "DIARRHEA".  Additional information: Patient received both pfizer covid vaccines. He continues to have nausea and diarrhea as side effects of bosulif(Dose: 500mg, Expiration Date: 31Dec2023)  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE  ACUTE ON CHRONIC HYPOXEMIC RESPIRATORY FAILURE HYPOXEMIA
Changes in menstrual cycle (closer together); herpes outbreaks monthly; This is a spontaneous report from a contactable consumer, the patient. A 39-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8734) via an unspecified route of administration in the left arm on 06Apr2021 at 13:15 (at the age of 39-year-old), as a single dose for COVID-19 immunisation. Medical history included herpes, but only one outbreak in the last 9 years. The patient had no known allergies. Prior to vaccination, it was unknown whether the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Concomitant medications included fluoxetine (MANUFACTURER UNKNOWN) and propranolol (MANUFACTURER UNKNOWN); both for unknown indication from unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: CD7534) via an unspecified route of administration in the left arm on 16Mar2021 at 15:00 (at the age of 39-year-old), as a single dose for COVID-19 immunisation. On 08Jun2021 at 13:00, the patient experienced changes in menstrual cycle (closer together) and had herpes outbreaks monthly. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were taken as a result of the events which included treatment with unspecified medication. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events changes in menstrual cycle (closer together) and herpes outbreaks monthly was not resolved at the time of this report.
Received Pfizer 1/22/2021. RNA+ 2/4/2021. S/S SOB, cough, confusion. COVID assoc. resp. failure, stage 4 lung cancer, COPD, HTN, former smoker. patient in hospice  and died 2/10/2021.
No additional AE reported; Patient was administered improperly stored VARIVAX at 8:30 AM on 04/04/2022; This spontaneous report was received from a registered nurse referring to a patient of unknown age and gender. Concomitant medication, pertinent medical history and drug reactions/allergies were not reported.  On 04-APR-2022 08:30, the patient was vaccinated with improperly stored varicella virus vaccine live (oka/merck)(VARIVAX) (strength, dose and route were not reported; lot # U008181, expiration date: 08-FEB-2023) for prophylaxis (product storage error).  It was reported that the suspect vaccine was exposed to a temperature of minus 10 degree Celsius up to 8 degree Celsius (2.20 C (also reported as the max temperature reached to 2.20 C) for a time frame of 1 hour and 15 minutes. No additional adverse event was reported.
pt recvd 2nd MMR vax on 6SEP91 & devel redness, warmth & 4+ edema @ inject site on arm; no further details were provided;
One day post vax, the child was hospitalized for erythema multiforme over the entire body. The child is being treated with Solu-Medrol therapy. The week prior to this event, the child received therapy with Augmentin for the treatment of an ear infection.
Hair loss starting 5 days after vaccination, leading up to complete hair loss on day 7.
I had nausea, headache, and fever.  I called the doctor that day and I had already had the nausea, and fever for 3 days and they stated that was just a side effect of the vaccine and it would pass.  I had a headache for a week and the nausea and fever had already resolved by the time the headache went away.
A 39 year old female patient received on 04 October 2007 a dose of Adacel (Lot #C2770AA) intramuscular into the left arm.  The next day, on 05 October 2007, she experienced injection site pain and pain in the entire left shoulder.  The patient had full range of motion.  X-ray of left shoulder was normal.  Anti-inflammatory medication was prescribed.  The patient's medical history included hypothyroidism and the patient's concomitant medications included Synthroid.  The patient's outcome was not reported.
Pt recv vax on 10/26/98; six hr post vax pt exp erythema, raised, indurated, hot vax site w/ urticaria & itching
Parents noticed that the right side of patient's face did not move on 5/10/17. Patient was otherwise acting well with no fever. Patient was referred to Neurology and see on 5/10/17. Neurology confirmed the Bell's palsy diagnosis. Patient was observed and did not receive any treatment and the Bell's palsy resolved within 2 weeks.
chills; fever; fatigue; This is a spontaneous report from a contactable consumer (patient).   A patient of unspecified age and gender received bnt162b2 (BNT162B2), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as DOSE 2, SINGLE for covid-19 immunisation.  The patient's medical history and concomitant medications were not reported.  The patient experienced chills, fever, and fatigue.  The outcome of the events was recovered after 24hours.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
after waiting the 15 minutes, pt came back to pharmacy window to report that she felt a little dizzy and got very hot very suddenly. So I had her sit down and apply a cold pack to her neck. The feeling passed in about 5 -10 minutes. She felt well enough to walk out on her own.
At 5:15 PM the day after receiving the DTaP vaccine my son vomited thick clear liquid every 5-10 minutes until 6:30 PM. He vomited a total of 7 times.
This spontaneous report as received from a medical assistant refers to a 13 year old patient of unknown gender. On 02-FEB-2016, the patient was vaccinated with improperly stored GARDASIL 9 (dose, anatomical location and route of administration were not provided, lot # L027282 with expiration date 21-SEP-2017). The vaccine underwent temperature excursion of either +1 or -1 degree Celsius for 255.5 total cumulative hours, which was detected by a data logger. There was no previous temperature excursion. No adverse effects were reported. This is one of several reports received from the same reporter. Additional information had been requested.
I woke up at 1:00AM with a fever, chills, extreme body aches, chest congestion, difficulty breathing, headache, and sore throat. I took home testing and it was giving me a negative reading. I went to my doctor on 1/13/2022 and got a positive COVID-19 test. I was prescribed a steroid, Albuterol sulfate, and Budesonide. My fever and body aches lasted 2-3 days. Chest congestion and cough took about a month to clear. I did take natural supplements that seemed to help: black seed oil, Quercetin, zinc, Vitamin C, Vitamin D, and NAC.
Since Day 8 after the vaccine, started tinnitus and headache . Tinnitus is non-stop 24 hours, headache come everyday, sometimes  morning A little less
Approx. 11.5 hrs post vx, pt unresponsive, limp with fever of 106.7. Taken to ER and transf. to hosp. where pt had tonic-clonic seizure (family hx-sister with febrile seizure). pt also had encephalopathy-tx with phenobarbital.
07/22-Have you had close contact* with a person who has a LABORATORY CONFIRMED case of COVID-19 in the past 14 days?: Yes- provide quarantine instructions unless exceptions met. (Continue Screening) (7/17) In the last 48 hours, have you had a fever* OR symptoms that are unrelated to a preexisting illness?: New cough, Fever (generalized weakness and dizziness)
Pt developed redness, swelling, and firmness encompassing left upper arm. She also developed blisters around the injection site. No sign of infection and treated with Benadryl.
areas on body that were inflamed; she felt more itchy; This is a spontaneous report from a contactable consumer or other non-HCP (patient herself) through a Pfizer-sponsored program via Medical Information Team. A female patient of unspecified age received BNT162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot number- UNKNOWN) via an unspecified route of administration on 23Feb2021 as dose 1, single for COVID-19 immunization. Patient relevant medical history included cut on fingers and insect bites. Patient experienced she had areas on body that were inflamed. Her cuts were inflamed on her fingers and she had insect bites that were inflamed. A few days after the shot it just seemed more inflammed and she felt more itchy but did not have a rash on an unspecified date in 2021. She was overall really itchy and things got more inflamed that were already inflamed but it has calmed down to where it was before. Patient stated she took the first dose of the vaccine and at that time it was very windy and the vials were blown away and were shaken but she did not confirm they were broken. She stated that shaken was not quite the right word and saw that it was important that the vials were not agitated. She stated that this happened right before she was going to get her shot. The entire cart blew over and she assumed the vaccine was on there. She stated that she had a side effect after the first dose. She stated she had areas on body that were inflamed. Her cuts were inflamed on her fingers and she had insect bites that were inflamed. A few days after the shot it just seemed more inflammed and she felt more itchy but did not have a rash. She was overall really itchy and things got more inflamed that were already inflamed but it had calmed down to where it was before. She asked about taking an anti-inflammatory patch for a knee. She stated a friend was saying something about not taking anti-inflammatories. She asked if it was okay to take anti-inflammatory vitamins like turmeric or an anti-inflammatory patch. She took the first dose last 23Feb2021. She would like to ask if it was ok to administer vials that were dropped on the floor. Any unaddressed medical questions were referred or forwarded to Medical Information. The outcome of the events was unknown.  No follow-up attempts are Possible. Information on Lot/batch number cannot be obtained.
Patient is a 45-year-old male that five (5)-minutes after receiving COVID-19 vaccine, experienced nausea and became light headed. Patient indicated that he always has been afraid of needles and in particular he was afraid of receiving the COVID-19 vaccine. Paramedic on site evaluated the vitals on the patient, revealing an oxygen saturation of 98%, HR 100, RR20 and BP 110/70. The patient was placed on a medical cot for about 20-minutes (supine position) and recovered without the need of administering any medication. At 12:30pm. the patient left the facility accompanied by his wife and walking on his own without any assistance.
6/17/09 Dr reported to me that 3 days ago he started with some numbness to left axilla and lateral upper arm.  6/17/09 50% better.  6/22/09 90% better.
This spontaneous report as received from a nurse via company representative refers to a 12 or 13 years old male patient. The patient's concurrent conditions, pertinent medical history and concomitant therapy were not reported. On unknown date in 2016, the patient was vaccinated with a dose of GARDASIL 9 or with a dose of GARDASIL (dose, lot #, expiration date and route were not reported) for prophylaxis. On unknown date, the patient experienced a "stroke" (cerebrovascular accident). The patient sought medical attention and he received unspecified medical treatment from an unspecified Healthcare Provider. Also, the patient was experiencing "debilitating issues and needs to use a wheelchair" (asthenia). At the time of the report, the outcome of cerebrovascular accident and asthenia was reported as not resolved. The relationship between cerebrovascular accident, asthenia and GARDASIL 9 or GARDASIL was not reported.  Cerebrovascular accident and asthenia were considered to be disabling by the nurse due to the patient was in a wheelchair. Upon internal review, cerebrovascular accident was determined to be medically significant.